SSJ Colleagues,

I am pleased to announce the publication of my new book on the global innovation system for new drug discovery. It includes a chapter on Japan's health diplomacy and innovation policy. Blurb appended below.

I am also writing a teaching note to go with it in case you are interested in adopting it for a course. Complimentary e-examination copies available.

Sincerely,

Kathryn

Dr. Ibata-Arens, Vincent de Paul Professor and Research and Innovation Leadership Fellow, Office of the Provost Department of Political Science, DePaul University Chair, Executive Committee, Society of Vincent de Paul Professors (2021-2022)

Book on Innovation and Entrepreneurship in Asia, Stanford University Press <https://www.sup.org/books/title/?id=24171>

Forthcoming book Pandemic Medicine: Why Our Global Innovation System is Broken and How We Can Fix It <https://www.rienner.com/title/Pandemic_Medicine_Why_the_Global_Innovation_System_is_Broken_and_How_We_Can_Fix_It>

LinkedIn Profile
<https://www.linkedin.com/in/kathryn-ibata-arens>Publications Free Download via ResearchGate <https://www.researchgate.net/profile/Kathryn_Ibata-Arens>


Pandemic Medicine: Why the Global Innovation System Is Broken, and
How We Can Fix It
<https://www.rienner.com/title/Pandemic_Medicine_Why_the_Global_Innovation_System_is_Broken_and_How_We_Can_Fix_It>

Kathryn C. Ibata-Arens

*DESCRIPTION*

Despite a century of advances in modern medicine, as well as the rapid development of Covid vaccines, the global pharmaceutical industry has largely failed to bring to market drugs that actually cure disease. Why? And looking further ... How can government policies stimulate investment in the development of curative drugs? Is there an untapped potential for "natural medicines" in new drug discovery? How have private-public sector partnerships transformed the ways we innovate? To what extent are medicinal plant biodiversity and human health codependent?

Addressing this range of increasingly critical questions, Kathryn Ibata-Arens analyzes the rise and decline of the global innovation system for new drug development and proposes a policy framework for fast-tracking the implementation of new discoveries and preparing for future pandemics.

*ABOUT THE AUTHOR*

*Kathryn C. Ibata-Arens* is Vincent de Paul Professor of Political Economy at DePaul University.

*CONTENTS*

* An Innovation Commons: The Global System for New Drug Discovery.
* Twilight of the (Big Pharma) Gods: The Rise and Decline of Innovation.
* Books of Remedies: China's Drug (Re)Discovery Politics.
* The Turmeric War: India Takes on the World Trade Organization and
Big Pharma.
* Medicine Gardens: Japan's Investment in New Drug Discovery.
* A Way Forward: Bringing Innovative Solutions to Global Hum